There is a strong rationale for using vitamin D in combination with anti-osteoporotic drugs. Still, available trials do not give clear indications in this setting, presenting a suboptimal and heavily inhomogeneous experimental design. Health authorities should revise requirements for using vitamin D in anti-osteoporotic drug trials to maximise their effect and produce reliable indications for clinical practice in this setting.
Use of vitamin D with anti-osteoporotic drugs: are available clinical trials telling us the whole story? / di Filippo, Luigi; Ulivieri, Fabio Massimo; Nuti, Ranuccio; Giustina, Andrea. - In: ENDOCRINE. - ISSN 1559-0100. - 83:2(2024), pp. 342-348. [10.1007/s12020-023-03551-z]
Use of vitamin D with anti-osteoporotic drugs: are available clinical trials telling us the whole story?
di Filippo, LuigiPrimo
;Giustina, Andrea
Ultimo
2024-01-01
Abstract
There is a strong rationale for using vitamin D in combination with anti-osteoporotic drugs. Still, available trials do not give clear indications in this setting, presenting a suboptimal and heavily inhomogeneous experimental design. Health authorities should revise requirements for using vitamin D in anti-osteoporotic drug trials to maximise their effect and produce reliable indications for clinical practice in this setting.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
